Clinical Observation of Various Types of Idiopathic Hypertrophic Cranial Pachymeningitis

World Neurosurg. 2024 Jan:181:e493-e503. doi: 10.1016/j.wneu.2023.10.087. Epub 2023 Oct 26.

Abstract

Background: To assist doctors in making better treatment decisions and improve patient prognosis, it is important to determine which therapy modalities are suitable for various forms of idiopathic hypertrophic cranial pachymeningitis (IHCP).

Methods: All cases were received from the hospital medical record system, and some follow-up information was gathered through telephone follow-up.

Results: A total of 26 patients, 14 men and 12 women, with ages ranging from 20 to 73 years and a mean of 47.42 years, were included in the research. Regular types were less likely to recur than irregular and nodular types, focal types were less likely to recur than diffuse types, and corticosteroid-refractory types were more likely to recur than corticosteroid-sensitive types.

Conclusions: The extent and shape of the lesion and susceptibility to corticosteroids are potential factors that could influence recurrence. Futhermore, this paper also proposes the fibroblasts as a new therapeutic target which may improve the quality of prognostic survival of patients.

Keywords: Clinical observation; Corticosteroid; Fibroblasts; Hypertrophic cranial pachymeningitis; Idiopathic.

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Decision Making
  • Dura Mater / pathology
  • Female
  • Fibroblasts / pathology
  • Humans
  • Hypertrophy / pathology
  • Magnetic Resonance Imaging
  • Male
  • Meningitis* / pathology

Substances

  • Adrenal Cortex Hormones